TapewireFind a company

person · Reporting owner

Fitzpatrick Edward J.

Disclosed activity across 2 companies

Tapewire entity
46419
SEC CIK
0001454029

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Cboe Global Markets, Inc.CBOE · Entity 3134DirectorMay 14, 2026May 18, 2026
Genpact LTDG · Entity 3760Senior Vice PresidentAugust 10, 2021August 12, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cboe Global Markets, Inc.

Report date May 14, 2026 · Filed May 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect13,451 Reported balance After 2026-05-14 transaction · row 1
1 source row

Row 1 · 2026-05-14 · Grant · Acquired 530 · Balance 13,451

F1: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date.

Genpact LTD

Report date August 10, 2021 · Filed August 12, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common SharesSEC Table I · non-derivativeDirect151,207 Reported balance After 2021-08-10 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2021-08-10 · Exercise / conversion · Acquired 8,589 · Balance 151,207

F1: Includes 26 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 9, 2021. The reporting person currently holds a total of 7,503 shares under the ESPP.

Common SharesSEC Table I · non-derivativeDirect142,618 Reported balance After 2021-08-10 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2021-08-10 · Sale · Disposed 8,589 · Balance 142,618

F2: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $51.05 to $51.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Common SharesSEC Table I · non-derivativeDirect259,029 Reported balance After 2021-08-11 transaction · row 3 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 3 · 2021-08-11 · Exercise / conversion · Acquired 116,411 · Balance 259,029

Common SharesSEC Table I · non-derivativeDirect142,618 Reported balance After 2021-08-11 transaction · row 4 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 4 · 2021-08-11 · Sale · Disposed 116,411 · Balance 142,618

F3: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $50.56 to $51.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.05 · Expires 2024-07-14Direct241,411 Reported balance After 2021-08-10 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2021-08-10 · Exercise / conversion · Disposed 8,589 · Balance 241,411

F4: The option vested 50% on July 15, 2017 and 50% on July 15, 2019.

Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.05 · Expires 2024-07-14Direct125,000 Reported balance After 2021-08-11 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2021-08-11 · Exercise / conversion · Disposed 116,411 · Balance 125,000

F4: The option vested 50% on July 15, 2017 and 50% on July 15, 2019.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 26 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 9, 2021. The reporting person currently holds a total of 7,503 shares under the ESPP.

F2: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $51.05 to $51.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $50.56 to $51.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: The option vested 50% on July 15, 2017 and 50% on July 15, 2019.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2026 Filed May 18, 2026 15:30 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 530 $0.00 $0.00
Disclosure

SEC source: 0001454029-26-000003 · form4-05182026_030517.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,451

F1 · price: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 16:30 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 SaleCommon Stock 3,947 $285.87 $1,128,328.89
Disclosure

SEC source: 0001454029-26-000002 · form4-02202026_090248.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,921

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.79 to $286.14. The reporting person undertakes to provide to Cboe Global Markets, Inc., any security holder of Cboe Global Markets, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 06, 2025 Filed May 8, 2025 16:40 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 729 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-012370 · form4-05082025_080526.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,868

F1 · price: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 6, 2026, provided that the filing person has remained in service continuously through such date.

Read SEC document
May 16, 2024 Filed May 20, 2024 16:38 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 937 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-013772 · form4-05202024_080547.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,139

F1 · price: Represents a restricted stock unit award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 16, 2025, provided that the filing person has remained in service continuously through such date.

Read SEC document
May 11, 2023 Filed May 15, 2023 16:39 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 1,223 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007999 · form4-05152023_080557.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,202

F1 · price: Represents a restricted stock unit award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 11, 2024, provided that the filing person has remained in service continuously through such date.

Read SEC document
May 12, 2022 Filed May 16, 2022 16:12 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 1,448 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-005010 · form4-05162022_010557.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,979

F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3.

Read SEC document
August 11, 2021 Filed Aug 12, 2021 16:11 UTC Genpact LTD G · Entity 3760 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 116,411 $0.00 Strike: $18.05 $0.00
Disclosure

SEC source: 0001567619-21-015260 · doc1.xml · derivative · entry 6

Fitzpatrick Edward J. · CIK 0001454029 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Shares · 116,411 shares

Expires 2024-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested 50% on July 15, 2017 and 50% on July 15, 2019.

Read SEC document
August 11, 2021 Filed Aug 12, 2021 16:11 UTC Genpact LTD G · Entity 3760 SaleCommon Shares 116,411 $51.03 $5,940,302.00
Disclosure

SEC source: 0001567619-21-015260 · doc1.xml · nonDerivative · entry 4

Fitzpatrick Edward J. · CIK 0001454029 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,618

F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $50.56 to $51.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 11, 2021 Filed Aug 12, 2021 16:11 UTC Genpact LTD G · Entity 3760 Exercise / conversionCommon Shares 116,411 $18.05 $2,101,218.55
Disclosure

SEC source: 0001567619-21-015260 · doc1.xml · nonDerivative · entry 3

Fitzpatrick Edward J. · CIK 0001454029 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 10, 2021 Filed Aug 12, 2021 16:11 UTC Genpact LTD G · Entity 3760 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 8,589 $0.00 Strike: $18.05 $0.00
Disclosure

SEC source: 0001567619-21-015260 · doc1.xml · derivative · entry 5

Fitzpatrick Edward J. · CIK 0001454029 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,411

Underlying: Common Shares · 8,589 shares

Expires 2024-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested 50% on July 15, 2017 and 50% on July 15, 2019.

Read SEC document
August 10, 2021 Filed Aug 12, 2021 16:11 UTC Genpact LTD G · Entity 3760 SaleCommon Shares 8,589 $51.07 $438,657.41
Disclosure

SEC source: 0001567619-21-015260 · doc1.xml · nonDerivative · entry 2

Fitzpatrick Edward J. · CIK 0001454029 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,618

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $51.05 to $51.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 10, 2021 Filed Aug 12, 2021 16:11 UTC Genpact LTD G · Entity 3760 Exercise / conversionCommon Shares 8,589 $18.05 $155,031.45
Disclosure

SEC source: 0001567619-21-015260 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,207

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 26 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 9, 2021. The reporting person currently holds a total of 7,503 shares under the ESPP.

Read SEC document
May 13, 2021 Filed May 17, 2021 16:19 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 1,276 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-005407 · edgar.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,531

F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3.

Read SEC document
March 08, 2021 Filed Mar 9, 2021 16:04 UTC Genpact LTD G · Entity 3760 SaleCommon Shares 30,583 $41.94 $1,282,669.37
Disclosure

SEC source: 0001567619-21-005912 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,592

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $41.50 to $42.06. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2 · balance_after: Includes 589 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 13, 2021. The reporting person currently holds a total of 7,477 shares under the ESPP.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 16:12 UTC Genpact LTD G · Entity 3760 Tax withholdingCommon Shares 21,107 $41.50 $875,940.50
Disclosure

SEC source: 0001567619-21-000972 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,586

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on April 2, 2018 under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Read SEC document
May 22, 2020 Filed May 26, 2020 16:06 UTC Genpact LTD G · Entity 3760 PurchaseCommon Shares 5,600 $33.72 $188,814.64
Disclosure

SEC source: 0001567619-20-011155 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,693

F1 · price: The price in Column 4 is a weighted average price. The actual purchase prices for these transactions ranged from $33.71 to $33.73. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.

Read SEC document
May 15, 2020 Filed May 19, 2020 16:05 UTC Genpact LTD G · Entity 3760 PurchaseCommon Shares 1,400 $32.58 $45,612.00
Disclosure

SEC source: 0001567619-20-010751 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,093

F1 · price: The price in Column 4 is a weighted average price. The actual purchase prices for these transactions ranged from $32.57 to $32.60. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.

F2 · balance_after: Includes 614 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on February 21, 2020. The reporting person currently holds a total of 6,888 shares under the ESPP.

Read SEC document
May 12, 2020 Filed May 14, 2020 16:22 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 1,482 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-005983 · edgar.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,255

F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3.

Read SEC document
February 19, 2020 Filed Feb 21, 2020 16:10 UTC Genpact LTD G · Entity 3760 GrantCommon Shares 70,183 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-004560 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,079

F1 · shares: The reporting person was granted performance share units (PSUs) on February 13, 2019 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2022 subject to the reporting person's continued service through such date.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 16:11 UTC Genpact LTD G · Entity 3760 Tax withholdingCommon Shares 22,838 $43.49 $993,224.62
Disclosure

SEC source: 0001567619-20-001443 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,896

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on March 30, 2017 under the Genpact Limited 2007 Omnibus Incentive Compensation Plan.

F2 · balance_after: Includes 811 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on February 21, 2019. The reporting person currently holds a total of 6,274 shares under the ESPP.

Read SEC document
May 16, 2019 Filed May 20, 2019 17:12 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 1,236 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-006393 · edgar.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,773

F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3.

Read SEC document
February 19, 2019 Filed Feb 21, 2019 16:09 UTC Genpact LTD G · Entity 3760 SaleCommon Shares 50,213 $33.03 $1,658,711.14
Disclosure

SEC source: 0001567619-19-005088 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,923

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $33.00 to $33.065. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 13, 2019 Filed Feb 15, 2019 16:11 UTC Genpact LTD G · Entity 3760 GrantCommon Shares 57,947 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-004625 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,136

F1 · shares: The reporting person was granted performance share units (PSUs) on April 2, 2018 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2021 subject to the reporting person's continued service through such date.

Read SEC document
January 10, 2019 Filed Jan 14, 2019 16:05 UTC Genpact LTD G · Entity 3760 GrantEmployee Stock Option (Right to Buy) · Derivative 252,152 $0.00 Strike: $27.70 $0.00
Disclosure

SEC source: 0001567619-19-001110 · doc1.xml · derivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252,152

Underlying: Common Shares · 252,152 shares

Expires 2029-01-09

F1 · derivative.exercise_date: The option vests 50% on January 10, 2022 and 50% on January 10, 2024.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 16:05 UTC Genpact LTD G · Entity 3760 Tax withholdingCommon Shares 14,244 $29.93 $426,322.92
Disclosure

SEC source: 0001140361-18-032713 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,189

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2007 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.

Read SEC document
May 17, 2018 Filed May 21, 2018 16:10 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 1,108 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-007198 · edgar.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,537

F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3.

Read SEC document
April 03, 2018 Filed Apr 4, 2018 16:34 UTC Genpact LTD G · Entity 3760 GrantCommon Shares 53,421 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-017108 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,433

F1 · shares: The reporting person was granted performance share units (PSUs) on March 30, 2017 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2020 subject to the reporting person's continued service through such date.

F2 · balance_after: Includes 781 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 19, 2018. The reporting person currently holds a total of 5,463 shares under the ESPP.

Read SEC document
January 17, 2018 Filed Jan 19, 2018 16:07 UTC Genpact LTD G · Entity 3760 Tax withholdingCommon Shares 23,289 $33.36 $776,921.04
Disclosure

SEC source: 0001140361-18-002600 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,231

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on March 9, 2015 under the Genpact Limited 2007 Omnibus Incentive Compensation Plan.

Read SEC document
August 22, 2017 Filed Aug 24, 2017 16:08 UTC Genpact LTD G · Entity 3760 SaleCommon Shares 57,934 $28.54 $1,653,372.63
Disclosure

SEC source: 0001140361-17-033175 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,520

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $28.50 to $28.61. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
July 18, 2017 Filed Jul 20, 2017 16:03 UTC Genpact LTD G · Entity 3760 Tax withholdingCommon Shares 12,019 $27.90 $335,330.10
Disclosure

SEC source: 0001140361-17-028282 · doc1.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,454

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2007 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.

F2 · balance_after: Includes 1,052 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on August 22, 2016. The reporting person currently holds a total of 4,682 shares under the ESPP.

Read SEC document
May 18, 2017 Filed May 22, 2017 17:43 UTC Cboe Global Markets, Inc. CBOE · Entity 3134 GrantCommon Stock 1,185 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-007741 · edgar.xml · nonDerivative · entry 1

Fitzpatrick Edward J. · CIK 0001454029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,429

F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.